ASML vs LRCX

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

LRCX presents a dichotomy between operational excellence and valuation extremes. The Piotroski F-Score of 4/9 indicates stable financial health, but the stock is trading at a massive premium to its Graham Number ($29.53) and Intrinsic Value ($141.01). While the company boasts an exceptional ROE of 65.56% and a stellar 25-quarter earnings beat record, the technical trend (10/100) and bearish insider activity ($29.66M in sales) suggest the current price may be overextended. The company is a high-quality compounder currently priced for perfection.